Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Clovis Oncology Inc (CLVS)

55.04 -0.44 (-0.79%)

5/25/2017  4:00pm

Open:

55.90

Pre. Close:

55.48

High:

55.90

Low:

54.82

Volume:

744,006

Market Cap:

2.46B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

56.33 - 57.93

57.93 - 58.75

Low:

52.1 - 53.4

53.4 - 54.07

Close:

53.51 - 55.74

55.74 - 56.89

Technical analysis  (as of: 2017-05-25 4:38:43 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 69.73     One year: 81.44

Support:

Support1: 50.87    Support2: 45.42

Resistance:

Resistance1: 59.70    Resistance2: 69.73

Pivot:

50.81

Moving Averages:

MA(5): 54.44     MA(20): 51.90

MA(100): 58.30     MA(250): 39.02

MACD:

MACD(12,26): -0.55     Signal(12,26,9): -1.58

%K %D:

%K(14,3): 84.85     %D(3): 75.44

RSI:

RSI(14): 53.89

52-Week:

High: 74.94  Low: 11.57  Change(%): 229.6

Average Vol(K):

3-Month: 164632  10-Days 94553

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CLVS has closed below upper band by 17.5%. Bollinger Bands are 1.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 25 May 2017 14:37:30 GMT
ValuEngine Lowers Clovis Oncology Inc (CLVS) to Sell

Wed, 03 May 2017 20:17:14 GMT
Clovis Oncology Announces First Quarter 2017 Operating Results

Thu, 27 Apr 2017 11:06:33 GMT
Myriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved ...

Mon, 22 May 2017 11:03:45 GMT
These two stocks are dominating the market, As Expected: Clovis Oncology, Inc ...

Wed, 17 May 2017 13:52:30 GMT
Apple, UnitedHealth, Clovis Oncology Upgraded

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

31.22

% Held by Insiders

10.02

% Held by Institutions

84.30

Shares Short (K)

7670

Shares Short Prior Month (K)

7810

Stock Financials

EPS

-8.130

EPS Est. Current Year

-4.950

EPS Est. Next Year

-2.770

EPS Est. Next Quarter

-1.200

Forward EPS

Book Value (p.s.)

3.890

PEG Ratio

-0.32

Profit Margin

Operating Margin

-374169.22

Return on Assets (ttm)

-33.8

Return on Equity (ttm)

-235.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

0.002

EBITDA (p.s.)

-6.514

Qtrly Earnings Growth

Operating Cash Flow (M)

-266.68

Levered Free Cash Flow (M)

-157.59

FoxReading.com

Valuation

P/E

-6.77

P/E Growth Ratio

-0.01

P/BV

14.15

P/S

31492.76

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.